# OXBRYTA

NDC: 72786-101
Generic name: Voxelotor
Labeler / Manufacturer: Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20191125

FDA application: NDA213137

## Active ingredients

- VOXELOTOR: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72786-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72786-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c557fac-29ec-483f-b691-8a935d4decc3